3D Medicines (HKSE:01244) Price-to-Free-Cash-Flow : N/A (As of May. 31, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines Price-to-Free-Cash-Flow?

As of today (2024-05-31), 3D Medicines's share price is HK$6.42. 3D Medicines's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.74. Hence, 3D Medicines's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for 3D Medicines's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:01244's Price-to-Free-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 30.41
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

3D Medicines's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.11. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$-0.74.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 18.70% per year.

During the past 4 years, 3D Medicines's highest 3-Year average Free Cash Flow per Share Growth Rate was 18.70% per year. The lowest was 18.70% per year. And the median was 18.70% per year.

3D Medicines Price-to-Free-Cash-Flow Historical Data

The historical data trend for 3D Medicines's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines Price-to-Free-Cash-Flow Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Free-Cash-Flow

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of 3D Medicines's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, 3D Medicines's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 3D Medicines's Price-to-Free-Cash-Flow falls into.

3D Medicines Price-to-Free-Cash-Flow Calculation

3D Medicines's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	6.42	/	-0.738
	=	N/A

3D Medicines's Share Price of today is HK$6.42.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3D Medicines's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.74.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

3D Medicines (HKSE:01244) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

3D Medicines Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of 3D Medicines's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

Executives

Gong Zhaolong	2101 Beneficial owner
Zhu Pai	2101 Beneficial owner
Dragon Prosper Holdings Limited	2101 Beneficial owner
Simcere Pharmaceutical Group Limited	2101 Beneficial owner
Gong Zhaolong	2501 Other
Immunal Medixin Us Limited	2101 Beneficial owner
Kastle Limited
Shanghai Zhenlu Enterprise Management Consulting Partnership (limited Partnership)	2101 Beneficial owner
Shenzhen Efung Holding Co., Ltd.	2201 Interest of corporation controlled by you
Shenzhen Efung Investment Management Enterprise (l.p.)	2201 Interest of corporation controlled by you
Shenzhen Efung Ruishi Investment Enterprise (limited Partnership)	2201 Interest of corporation controlled by you
Zhu Jinqiao	2103 Interests held jointly with another person

3D Medicines (HKSE:01244) Headlines

No Headlines